Precision medicine has demonstrated clinical utility and cost-effectiveness, which is why many believe this approach will be key to value-based cancer care in the future, said Jonathan Hirsch, founder and president of Syapse. – See more at: http://www.ajmc.com/interviews/jonathan-hirsch-explains-why-syapse-believes-precision-medicine-is-the-future-of-cancer-care#sthash.vsoTkSmu.dpuf